Extemporaneously compounded liquid formulations of clofazimine

BACKGROUND: Clofazimine (CFZ) is routinely used worldwide for the treatment of leprosy and TB. However, no liquid or dispersible tablet formulations of CFZ are currently available commercially for patients with challenges ingesting soft gelatin capsules or solid formulations. The aim of this researc...

Descripción completa

Detalles Bibliográficos
Autores principales: Taneja, R., Nahata, M. C., Scarim, J., Pande, P. G., Scarim, A., Hoddinott, G., Fourie, C. L., Jew, R. K., Schaaf, H. S., Hesseling, A. C., Garcia-Prats, A. J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International Union Against Tuberculosis and Lung Disease 2023
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9904399/
https://www.ncbi.nlm.nih.gov/pubmed/36853102
http://dx.doi.org/10.5588/ijtld.22.0331

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9904399/
https://www.ncbi.nlm.nih.gov/pubmed/36853102
http://dx.doi.org/10.5588/ijtld.22.0331

Ejemplares similares